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Eukaryotic genomes are methylated at cytosine bases in the context of CpG dinucleotides, a pattern which is maintained through
cell division by the DNA methyltransferase Dnmt1. Dramatic methylation losses are observed in plant and mouse cells lacking
Lsh (lymphoid specific helicase), predominantly at repetitive sequences and gene promoters. However, the mechanism by which
Lsh contributes to the maintenance of DNA methylation is unknown. Here we show that DNA methylation is lost in Lsh depleted
frog and fish embryos, both of which exhibit developmental delay. Additionally, we show that both Lsh and Dnmt1 are associated
with chromatin and that Lsh knockdown leads to a decreased Dnmt1-chromatin association. Coimmunoprecipitation experiments
reveal that Lsh and Dnmt1 are found in the same protein complex, and pulldowns show this interaction is direct. Our data indicate
that Lsh is usually diffuse in the nucleus but can be recruited to heterochromatin in a HP1𝛼-dependent manner.These data together
(a) show that the role of Lsh inDNAmethylation is conserved in plants, amphibian, fish, andmice and (b) support amodel in which
Lsh contributes to Dnmt1 binding to chromatin, explaining how its loss can potentially lead to perturbations in DNA methylation
maintenance.
1. Introduction
DNA methylation at the 5󸀠 cytosine position (5mC) in the
context of CpG dinucleotides plays a central role in gene
repression in most eukaryotes and flowering plants. 5mC
represents 1%of all nucleotides and 4%of all cytosine residues
in mammalian genomes and is required for a wide range
of biological processes including transcriptional silencing
[1]. Additionally, 5mC is involved in allele-specific genomic
imprinting, X chromosome inactivation in female cells, and
silencing of retrotransposons in germ cells and the soma [2].
Moreover, embryonic stem (ES) cells lacking DNA methyla-
tion are capable of self-renewal but are unable to differentiate
[3]. Two classes of DNAmethyltransferases have been widely
described in animals: Dnmt1 (maintenance methyltrans-
ferase) and Dnmt3a/3b (de novo methyltransferases) [4–8].
The heritability of the 5mCmark is, in part, accounted for by
the ability of Dnmt1 to faithfully remethylate DNA daughter
strands during and after replication ensuring appropriate
methylation patterns in future progeny [9]. Considerable
efforts have led to the conclusion that the role of the de novo
methyltransferases is to establish new methylation marks
following the postfertilisation wave of demethylation during
early embryogenesis and germ cell development [10–12].
Chromatin structure influences transcriptional states
within the mouse genome and can be broadly considered
in two different flavours: “active” euchromatin which is
enriched for histone marks associated with transcriptional
activity (i.e., H3K4me3,H3K27ac) and “inactive” heterochro-
matin (i.e., H3K27me3, H3K9me3) [13–16]. Interestingly,
H3K9me3 acts as a ligand for the chromodomain protein
HP1𝛼 thus reinforcing silencing of heterochromatin [17].
Another tier of chromatin conformation is controlled by
nucleosome remodelling complexes including the SWI/SNF
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family [18]. The SNF domain has been shown to be an
ATPase-dependent protein domain capable of shifting nucle-
osomes on chromatin templates, an effect which can expose
or obscure transcription factor binding sites [19]. Lymphoid
specific helicase (Lsh) (also known as Hells, PASG, and
SMARCA6) is a putative member of the SWI/SNF family
[20]; in addition to a SNF domain it harbours a helicase
motif which can bend/kinkDNAandRNAmolecules [21, 22].
Taking these two domains together implies that Lsh may be
involved in chromatin remodelling.This hypothesis has been
supported by the decreased global DNA methylation levels
observed at repeat elements and some single-copy genes in
Lsh deficient plants and mice [23–25].
Links between Lsh and DNA methylation have been
investigated extensively, but the mechanism by which inter-
ference of Lsh function contributes to global hypomethy-
lation remains incomplete [26–28]. Lsh was shown to be
dispensable for the recruitment of Dnmt1 to normal replica-
tion foci during late S phase [29]. However, support for an
association between Lsh and the maintenance methyltrans-
ferase Dnmt1 was suggested by the finding that transgene
silencing mediated via tethered Gal4-Lsh requires Dnmt1
in cooperation with histone deacetylases and the de novo
methyltransferase Dnmt3b [27]. Evidence of a link between
Lsh and heterochromatin structure arose from studies that
demonstrated that Lsh association with chromatin is lost in
cells treated with the histone deacetylase inhibitor, tricho-
statin A (TSA), which results in chromatin having a more
accessible hyperacetylated signature [29]. Additionally, loss
of Lsh leads to the accumulation of the “activating” mark
H3K4me2 globally [29], while the repressive mark H3K9me3
is reduced [26]. Lsh knockout mice die perinatally with gross
renal defects or shortly after birth with a spectrum of organ
defects and a premature aging phenotype
[30, 31].
We present evidence that Lsh is essential for the com-
pletion of a normal developmental program in amphibian
and fish [32]. In addition, we report that Lsh and Dnmt1 can
interact directly in vivo and in vitro but rarely colocalise at
heterochromatic foci in cells; however this can be enhanced
by the presence of HP1𝛼. Finally, we show that both Lsh
and Dnmt1 are chromatin bound and that Lsh is required
to recruit or facilitate the association between Dnmt1 and
chromatin. Taken together, this study demonstrates that Lsh
andDnmt1 are key protein partners and thismay underlie the
loss of DNAmethylation and embryonic defects that occur in
Lsh depleted embryos.
2. Materials and Methods
2.1. Embryos, Morpholinos, TNT Assay, and TUNEL. Xeno-
pus laevis and zebrafish were maintained using standard
procedures. All morpholinos were designed and obtained
from GeneTools LLC. Xenopus laevis 2-cell embryos were
microinjected into each blastomere (0.5–10 ng per cell) and
allowed to develop. Zebrafish stocks were maintained and
embryo cultures were as described previously [32]. Mor-
pholinos were injected (5–10 ng per cell) at the 1-cell stage.
Morpholino sequences: xLMO(5󸀠-AGCTCTGTCCCACAG-
GCATCTTATA-3󸀠; 5󸀠-TTGGGTCATCATCAGATGGTT-
CCAT-3󸀠); zLMO (5󸀠-GCTTGCTTTTTTCCATTGTGG-
TCTC-3󸀠); control-MO (5󸀠-CCTCTTACCTCAGTTACA-
ATTTATA-3󸀠). TNT assays were performed using a full-
length cDNA xLsh clone as template and were labelled with
35S-methionine. Assays were performed in the presence or
absence of 200 nMmorpholino and products were separated
by PAGE. TUNEL staining was carried out as described
[33]. TNT assays for GST-pulldowns were carried out by
amplifying T7 tagged mLsh and mDnmt1 by PCR with linker
primers. PCR products were added to the TNT Quick T7
for PCR DNA kit and translated in the presence of 35S-
methionine. Whole mount in situ hybridisation was carried
out as previously described [34].
2.2. Southern Blotting and DNADot Blotting. Genomic DNA
was isolated from embryo batches (∼50–100) in SETN buffer:
1% SDS, 1mM EDTA, 10mM Tris pH8, and 150mM NaCl.
Lysates were RNaseA treated, proteinase K treated, phenol-
extracted, and precipitated yielding high-integrity genomic
DNA. For southern analysis, 2–4𝜇g of DNA were digested to
completion with 10U HpaII orMspI in a reaction volume of
100 𝜇L for two hours at 37∘C followed by a further addition of
5U enzyme overnight at 37∘C. Southern blots were carried
out using established methods and probes for xSatI [35]
and Dana [36]. For dot blots DNA was dotted onto PVDF
(Bio-Rad) and membranes were baked for 2 hours at 80∘C
under vacuum and then probed with a monoclonal anti-5-
methylcytosine antibody (Eurogentec).
2.3. Bisulfite Sequencing. Genomic DNA (500 ng) was bisul-
fite converted using EZ DNA Methylation-Lightning Kit
(Zymo Research). PCR primers used were xSatI-Bis1 GTT-
AATATTAATTTGAGGTTTAG; xSatI-Bis2 GTTTGA-
ATAGTTTAGTTGGTAG; xSatI-Bis3 AAATACTAAATA-
AAAAAACCC; xSatI-Bis4 TTCAAACTAATACTAAAC-
AAAC. PCR products were cloned into pGEM-T Easy
(Promega) and sequenced using BigDye 3.1 sequencing
chemistry (Thermo Fisher Scientific) on an ABI Prism 3700
DNA Analyzer (Applied Biosystems).
2.4. Cell Culture. Mouse 3T3 and N2a cells and human
293T and SW620 cells were grown in DMEM supplemented
with 10% serum and 1% penicillin-streptomycin. p53−/− and
p53−/−/Dnmt1−/− mouse embryonic fibroblasts were grown
as described [37].
2.5. GST Pulldowns and Immunoprecipitations. GST and
GST-fusions were produced in BL21 cells and crudely iso-
lated using BugBuster (Novagen) followed by binding to
glutathione beads (GE HealthSciences). For pulldowns from
extracts, nuclear-enriched fractions were isolated using an
established method [38]. Briefly, cells were washed in PBS
and lysed using RSB-150 (10mM Tris pH 7.5, NaCl 150mM,
2.5mM MgCl
2
, 40 𝜇g/mL digitonin, and protease inhibitor
tablets (Roche)) on ice for 5 minutes followed by centrifu-
gation at 2000 g for 8 minutes at 4∘C. The cytoplasmic
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supernatant was discarded and the pellet was resuspended
in RSB-150 supplemented with 0.5% Triton X-100, passed
through a 40 𝜇M needle and harvested as before. Nuclear
extract supernatants were mixed with GST proteins for 1
hour at 4∘C, washed in RSB-150 three times, resuspended
in Laemmli buffer, and separated by PAGE. Tagged proteins
were transfected into 293T cells using Lipofectamine-2000
(Invitrogen) and nuclear extracts were prepared as above.
Extracts were precleared with protein G (AutoGen Bioclear)
and supplemented with antibodies overnight at 4∘C. Finally,
fresh protein G was added for one hour at 4∘C and complexes
were washed three times with RSB-150 and separated by
PAGE.
2.6. Direct Fluorescence. p53−/− MEF cells were grown on
coverslips and transfected with the indicated plasmids using
Lipofectamine-2000 (Invitrogen) for 24 hours. Cells were
washed twice in PBS, permeabilised in 0.1% Triton X-
100/PBS and stained in 0.1mg/mL DAPI. Coverslips were
mounted inVectashield on slides andwere visualised using an
Axioplan fluorescence microscope (Carl Zeiss, Welwyn, UK)
fitted with a Chroma 84000 quadruple-band pass filter set
(Chroma Technology, Rockingham, VT). Grayscale images
were captured with an Orca AG CCD (Hamamatsu Photon-
ics, Welwyn Garden City, Hertfordshire, UK).
2.7. siRNA, Sucrose Gradients, and Micrococcal Nuclease
Assays. siRNA duplexes (sequences available on request)
against human Lsh were obtained from Ambion (USA)
and were introduced into 293T cells using Oligofectamine
(Invitrogen). Knockdown efficiency was determined by
immunoblotting using a rabbit polyclonal Lsh antibody (gift
from Kathrin Muegge) compared to endogenous PCNA
(Abcam) levels. Soluble chromatin was released from mouse
3T3 nuclei using micrococcal nuclease (MNase) overnight
and fractionated over 6–40% isokinetic sucrose gradients as
described [39]. Fractions were precipitated using an equal
volume of 20% trichloroacetic acid and protein pellets were
washed in cold acetone and prepared for PAGE in Laemmli
buffer. DNA was isolated from gradient fractions by ethanol
precipitation and separated on 1x TPE agarose gels. MNase
release of chromatin associated proteins was essentially
performed as described [40]. Briefly, nuclei were isolated
from p53−/− cells using RSB-150 containing 0.5% Triton X-
100 and 20𝜇g DNA equivalents of nuclei were equilibrated
in 60𝜇L solution C (300mM sucrose, 50mM Tris pH8,
25mM KCl, 4mM MgCl
2
, and lmM CaCl
2
). Aliquots were
either untreated or digested with various unit amounts of
MNase for 15mins at room temperature and reactions were
stopped by supplementing with 20mM EDTA on ice for a
further 15mins. Released proteins in the supernatant were
isolated by centrifugation at 13,000 rpm for 10mins at 4∘Cand
both soluble and pellet fractions were processed for protein
isolation. The pellet fractions were also processed for DNA
isolation to monitor the dynamics of chromatin digestion by
MNase.
2.8. Western Blotting. Western blotting was carried out using
standard methods. In brief, proteins were resolved on 4–12%
precast gradient gels (Invitrogen) and transferred to PVDF
(Bio-Rad). Blots were blocked in 5% marvel milk in PBS
supplemented with 0.1% Tween 20 and incubated with the
appropriate antibody at 4∘C overnight. Western blot signals
were detected using alkaline-phosphatase secondary anti-
bodies (Bio-Rad) and exposed to film (GEHealthSciences).
3. Results and Discussion
3.1. Lsh Is Essential for Xenopus laevis and Danio rerio
Development. Lsh orthologs are highly conserved from yeast
to humans, and both temporal and spatial analyses show that
xLsh is expressed largely ubiquitously throughout allXenopus
laevis embryonic stages (see S1-S2 in Supplementary Mate-
rial available online at http://dx.doi.org/10.1155/2015/740637).
Studies in plants and mice have indicated that interference
with endogenous Lsh function by gene targeting results
in partial hypomethylation of the genome [23, 24, 26].
To address whether this finding is conserved in amphibia
and fish we depleted Lsh in Xenopus laevis and Danio
rerio embryos by microinjection with antisense morpholinos
that inhibit translation of the target mRNA [41]. Xenopus
Lsh (xLsh) morphants (xLMO) appeared normal through
the midblastula transition (MBT) and neurulation. In con-
trast, at early tailbud stages many xLMO embryos had
an aberrant phenotype in comparison with the control
morpholino injected siblings (Figure 1(a), left). xLMO mid-
tailbud embryos are axis-truncated and hyperventralised
and do not form proper head structures including the
eye, cement gland, and brain structures (Figure 1(a), middle
panel). xLMO tadpole abnormalities are more pronounced
(Figure 1(a), right) and by stages 44-45 (tadpole) many
mutants have no tail structure and lack eyes, mouth, and
head structures (Figure 1(b)). Successful microinjection and
morpholino stability are verified by UV detection of the
morpholino fluorescein tag (Figure 1(c)), indicating that the
morpholino is stable in vivo for over 3 days. In the absence
of a suitable antibody against xLsh, we demonstrated xLMO
knockdown efficacy by in vitro where translation of xLsh
mRNA was reduced reproducibly by 70% in the presence
of the morpholino (Figure 1(d)). To rule out nonspecific
inhibition by xLMO we repeated the same experiment with
recombinant radiolabelled luciferase, which was translated
efficiently (third lane in Figure 1(d) and data not shown).
Finally, we reproduced the similar axis-truncated late-stage
phenotype with an xLMO design targeting a different region
of the xLsh mRNA (data not shown). xDnmt1- and xKaiso-
depleted embryos both show general patterns of apoptosis
that is hallmark of their respective phenotypes [33, 42]. In
contrast the xLMOmorphants showed no significant TUNEL
positive staining (Supplementary S3).
We also tested Lsh depletion by morpholino (zLMO) in
the model system Danio rerio. Embryos were microinjected
and allowed to develop to 24 hours after fertilisation (hpf). By
titrating the dose of morpholino injected (5–10 ng/embryo),
we observed a developmental phenotype compared to wild
type embryos (Figure 1(e), compare zLMO and control MO).
Themorphant phenotype becomesmore pronounced: the tail
becomes shorter, somite numbers are reduced, and head and
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Figure 1: Lsh is essential for both Xenopus laevis and Danio rerio development. (a–c) Xenopus laevis embryos were injected with xLMO or
controlmorpholinos and allowed to develop. Each panel shows examples ofmorphant embryos and a control embryo (black arrows). xLMO is
fluorescein labelled and successfully injected embryos can be visualised under UV light (c). Developmental stages are (a) 28, 37-38, 42, (b) 42–
45, (c) 42–45. Scale bar = 1mm. (d) In vitro inhibition of xLsh coupled transcription-translation (TNT) with xLMO. 35S-Methionine labelled
xLsh protein was prepared by TNT in the presence or absence of xLMO and products separated by PAGE. xLsh production was inhibited by
xLMO (compare left andmiddle lanes). Band on lower right is TNT luciferase protein. (e)Danio rerio embryos were injected with zLMO and
allowed to develop to the midsomite stage (24 hpf). Severity of phenotype is dose-dependent (compare panels left to right). UV light showing
successful microinjection of three doses of zLMO and severity of phenotype (top panel, lateral view). Brightfield view of three doses of zLMO
(middle panel, lateral view). Two representative brightfield control morpholino injected embryos (lower panel, lateral view). Scale bar =
300 𝜇m. (f) Southern blot analysis of genomic DNA isolated from control- and xLMO-injected tadpole embryos using a dispersed repeat
xSatI probe. DNA was digested with either HpaII (methylation-sensitive) or MspI (methylation-insensitive HpaII isoschizomer), resolved
and probed with radiolabelled xSatI. Digestion with HpaII indicates that xLMO DNA from tadpoles is more frequently cut as indicated by
the lowmolecular weight banding pattern (black arrows) compared to control-injected genomic DNA. (g) Southern blot analysis of genomic
DNA isolated from control- and zLMO-injected 24 hpf embryos using a Danio rerio Dana probe. A similar approach was taken as in (f).
Compare the extent of HpaII digestion in lane 3 (control) and lane 4 (zLMO). Black bracket = wild type HpaII profile; dashed red bracket =
zLMO HpaII profile. DNA sizes are indicated in kilobases to the left of each gel. (h) Upper: dot blot of Xenopus laevis genomic DNA probed
with 5-methylcytosine antibody. Note the weaker binding of antibody to the xLMO DNA indicating global hypomethylation; lower: dot blot
of Danio rerio genomic DNA probed with 5-methylcytosine antibody. Note the reduced binding of antibody to the zLMO DNA indicating
global hypomethylation. (i) Summary of bisulfite sequencing of xSat in wild type and xLMO tadpole embryos. Vertical axis: % methylation;
horizontal axis: each CpG in xSat amplicon.
brain structures are primitively formed or absent in a dose-
dependent manner. Control morpholino injected embryos
are shown in Figure 1(e), bottom panel. For more detailed
information on embryo phenotypes and survival rates see
Supplementary Figures S4-S5.
3.2. DNA Hypomethylation Is Conserved in Lsh Depleted
Embryos. Interference with Lsh function in plants and mice
leads to a global DNA methylation deficit in embryos and
cultured cells [43]. Loss of Arabidopsis thaliana repeat-
associated DNAmethylation leads to increased rates of retro-
transposition, while loss of repetitive DNA methylation and
some single-copy genes occurs in Lsh−/− embryos. Whether
this is restricted to plants and mammals is unknown. Previ-
ously, we have shown that cytosine methylation is reduced
at an interspersed repeat sequence xSatI in xDnmt1-depleted
Xenopus embryos [42]. Using a similar approach, we tested if
DNA hypomethylation occurs at xSatI in xLMO morphants
by comparing the digestion profile of genomic DNA using
HpaII (methyl-sensitive) and MspI (methyl-insensitive). In
neurula staged embryos, we detected no detectable change
in methylation (data not shown). Upon probing with a
radiolabelled xSat probe, xLMO tadpole stage (coincident
with the morphant phenotype) embryonic DNA is sensitive
to HpaII digestion compared to control embryonic DNA
(Figure 1(f); compare low molecular weight smear in lanes
3 and 4; ethidium gel in Supplementary S6) confirming loss
of DNA methylation. We note that this loss of methylation is
partial as HpaII does not digest to the same extent asMspI.
To extend this analysis to fish, we digested control and
zLMO genomic DNA isolates from Danio rerio as above
and probed with a radiolabeled short interspersed repeat
element sequence termed Dana [36, 44]. The range of the
mean size HpaII digested zLMO DNA is shifted compared
to the mean size of the control DNA, but we did not observe
the appearance of the low molecular weight band observed
for MspI digestion (Figure 1(g), compare lanes 3 and 4;
black bracket (wild type); red bracket (zLMO); ethidium
gel in Supplementary S6). This suggests, like Lsh depletion
in mouse and Xenopus, that loss of DNA methylation in
zLMO morphants is partial, consistent with an incomplete
knockdown. To validate the observed restriction digestion
DNA hypomethylation results, we performed dot-blot anal-
ysis using a 5-methylcytosine antibody. Using this approach,
we can distinguish between control DNA and xLMO/zLMO
DNA, which has approximately 50% less methylated DNA
signal compared to the control (Figure 1(h)). Blots were
stained with methylene blue to show equal DNA loading
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(Supplementary S6; [45]). Taken together, these data imply
that Lsh is essential for normal development in frogs and
fish and that morphant embryos show partial losses in global
DNAmethylation levels. Finally, we used bisulfite sequencing
to examine repeat methylation [34] in xLMO tadpole DNA
compared to wild type DNA, showing loss of methylation
from the xSat interspersed repeat in morphant DNA across
seven CpG positions (Figure 1(i)). Taken together, this sug-
gests evolutionary conservation in Lsh function as a regulator
of DNAmethylation between plants, fish, frogs, and rodents.
3.3. Lsh and Dnmt1 Interact In Vivo and In Vitro. Dnmt1 is
the major DNA cytosine methyltransferase in mammalian
cells and has a prominent role in the faithful preservation
of DNA methylation patterns in daughter cells after DNA
replication. The most striking Lsh target sequences at which
DNA methylation is lost are repeat elements, which are
both templates for the maintenance (Dnmt1) and de novo
(Dnmt3a and 3b) methyltransferases in mice. To explain
the losses of repeat sequence methylation in Lsh depleted
cells we hypothesized that Lsh, which lacks an obvious
methyltransferase domain, may be a cofactor for Dnmt1 in
maintaining DNA methylation levels at repeat sequence loci
(and perhaps genes) and directly participate in their silencing
[20].
To test this hypothesis, we carried out biochemical assays
to determine if Dnmt1 and Lsh can interact. We first made
use of a panel of GST-mLsh and GST-hDnmt1 fusions
proteins, which we expressed, purified (Supplementary S6),
and used as bait for in vitro radiolabeled translated mLsh and
mDnmt (Figure 2(a)). We observed GST pulldown signals
from the N-terminal and C-terminal domain mLsh GST-
fusions for radiolabelled hDnmt1 (Figure 2(b), upper). We
note that the N-terminal domain of Lsh contains two coiled-
coil domains which are predicted to be protein-protein
interaction domains (PFAM: http://hmmer.janelia.org/). Sec-
ondly, the C-terminal domain of Lsh encompasses the heli-
case domain which may imply coupling between Lsh and
Dnmt1 at unwinding chromatin. The reciprocal experiment
(radiolabeled mLsh and GST-Dnmt1 fusions) showed robust
GST pulldown signals for all five hDnmt1 fusions with
strongest signals from GST-hDnmt1 (305–609) and GST-
hDnmt1 (1000–1632) (Figure 2(b), lower). Next, we tested
whether Lsh and Dnmt1 can interact in cellular contexts.
We coexpressed full-length tagged Dnmt1 and Lsh fusions
in highly transfectable human 293T cells and performed
coimmunoprecipitations. Both immunoprecipitated proteins
were capable of interacting with the partner tagged protein
(Figure 2(c) right, IP lanes). Finally, we wanted to test
whether endogenous Lsh and Dnmt1 can interact. Unrelated
experiments showed that the human colorectal cancer cell
line SW620 expresses high levels of both proteins (data not
shown) and blotting of hDnmt1 immunoprecipitates from
these cells gave a strong signal using a human Lsh antibody
(Figure 2(d)). We also performed these experiments in the
high salt conditions previously reported [27] and observed
the same interactions (data not shown). Collectively, these
biochemical experiments imply that Lsh and Dnmt1 interact
in vitro and in vivo and that this interaction can occur directly
without additional nuclear protein partners.
3.4. Bulk Lsh Is Predominantly Nuclear Diffuse. Cell biology
approaches in cultured murine cells suggest that Dnmt1 is
predominantly associated with pericentric heterochromatic
nuclear foci at S-phase; however this localisation may fluc-
tuate during the cell cycle and can be lost in cancer cells
[46–49]. Others have suggested that Lsh protein expression
is essentially nuclear and that this overlaps with Dnmt1
and PCNA at replication foci in late S-phase but not in
interphase nuclei [29]. To further explore these findings,
we took advantage of a p53−/− MEF cell line [37] which is
resistant to overexpression induced cell death to determine
Lsh localisation.We observed mouse Lsh (cherry red tagged)
to be nuclear diffuse in the majority of nuclei and in some
cases present at subtle nuclear foci which overlap in part with
pericentric heterochromatin (Figure 2(e), compare upper
and lower panels), which implies that the majority of Lsh
protein is not associated with pericentric heterochromatin in
MEFs. In addition, we tested a T7-tagged xLsh fusion and
GFP mLsh in additional mouse cells largely showing diffuse
nuclear staining in >90% of cells (Supplementary S7). We
detected a similar nuclear diffuse pattern with the previously
published GFP-tagged mLsh fusion [29] (Figure 2(f), top
panel). In contrast, we observed both GFP-xDnmt1 and GFP-
hDnmt1 colocalise with DAPI bright pericentric heterochro-
matin in up to 50% cells; otherwise these Dnmt1 fusions
were nuclear diffuse in the remaining cells (Supplementary
S7). Efforts to recruit exogenous Lsh from diffuse nuclear
staining to heterochromatic foci in the presence of exogenous
Dnmt1 were unsuccessful in p53−/− MEFs; however we
observe widespread nuclear diffuse colocalisation implying
that these proteins overlap at nonheterochromatic regions in
the nucleus (Supplementary S7). In summary, the bulk of Lsh
is diffusely stained across nuclei from a variety of cells types
with a minor fraction localising with heterochromatic foci.
3.5. HP1𝛼 Can Recruit Lsh to Heterochromatin. A role for
Lsh in regulation of histone methylation and the formation
of normal heterochromatin was proposed in experiments
which demonstrated that H3K4me2 levels were increased
in Lsh−/− cells and this could be recapitulated by treating
cells with 5󸀠-azacytidine [50]. This suggests a pathway where
loss of DNA methylation precedes the gain of activating
histone marks at normally silent loci in Lsh−/− cells. Lsh
can colocalise with and precipitate HP1𝛼 after cross-linking
suggesting a close (if not direct) association of Lsh with HP1𝛼
on heterochromatic nucleosomes [29]. Thus, it is possible
that HP1𝛼 facilitates Lsh localisation to heterochromatin.
To investigate this we explored the localisation of HP1𝛼
together with Lsh in p53−/− MEFs. As expected, GFP-HP1𝛼
localises almost exclusively to heterochromatic DAPI bright
spots (Figure 2(f), bottom panel). In the presence of HP1𝛼we
observed a higher proportion of cells (>30%) exhibiting Lsh
accumulation at heterochromatin (Figure 2(g)), compared
to expression of Lsh alone (Figure 2(e)) implying that an
exogenous pool of active HP1𝛼 is sufficient to drive Lsh to
BioMed Research International 7
GSTmLsh
GSTmDnmt1
MTase
NLS PCNA Zn-finger Bromodomain
Snf2 HelicaseNLSCC
1125–1620740–1115613–740305–6091–343
560–822211–560
1–208
(a)
mLsh (aa)
mDnmt1 (aa)
205
95
(kDa)
G
ST
G
STIn
pu
t
(1
0%
)
In
pu
t
(1
0%
)
(kDa)
35S-mDnmt1
35S-mLsh
1
1
2
5
–1
6
2
0
7
4
0
–1
1
1
5
6
1
3
–7
4
0
3
0
5
–6
0
9
1
–3
4
3
5
6
0
–8
2
2
2
1
1
–5
6
0
1
–2
0
8
(b)
IgGIn Lsh
Dnmt1IgGIn
205
95
(kDa)
𝛼Dnmt1
𝛼Lsh
(c)
Dnmt1IgGIn
95
(kDa)
𝛼Lsh
(d)
85%
15%
DAPI mLsh Merge
(e)
DAPI mLsh Merge
(f)
DAPI MergehHP1𝛼
(g)
DAPI
mLsh
30%
X
hHP1𝛼
(h)
100%
DAPI
mLsh +
hHP1𝛼V21M
(i)
100%
DAPI
xLsh +
hHP1𝛼A129R
(j)
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heterochromatin. Coexpression of HP1𝛼 mutants with Lsh
(HP1𝛼V21M: chromodomain mutant; HP1𝛼A129R chromo
shadow domain mutant) abrogates Lsh presence at hete-
rochromatic foci implying that wild type HP1𝛼 is sufficient
and necessary to recruit Lsh to heterochromatin (Figures
2(h)–2(j)). Interestingly, as we have found for Lsh, HP1 family
members are known to interact directly with Dnmt1 and
mediate its activity [8].
3.6. Lsh Can Recruit Dnmt1 to Chromatin and Can Repress
a Nonmethylated Reporter Gene. Previous studies have high-
lighted that Lsh is chromatin associated by showing its pres-
ence in the detergent insoluble chromatin fraction derived
from mouse nuclei [29]. To test this orthogonally, we exam-
ined the coupling of Lsh to chromatin by treating 293T
nuclei with micrococcal nuclease (MNase) and assaying
for the presence of Lsh in the supernatant (soluble and
free) or pellet (insoluble and chromatin bound) [40]. As
shown in Figure 3(a), endogenous Lsh is absent from the
supernatants of untreated nuclei, in contrast to the high levels
present in the soluble fraction ofMNase treated nuclei, which
demonstrates that Lsh is tightly coupled to chromatin. A
similar finding was seen for endogenous Dnmt1 using the
same assay (Figure 3(a)). An alternative method of assay-
ing for chromatin bound proteins is fractionating soluble
chromatin by sedimentation across sucrose gradients [39]
followed by immunoblotting for the protein of interest. We
fractionated mouse 3T3 soluble chromatin across isokinetic
6–40% sucrose gradients and precipitated the protein from
each fraction and blotted for endogenous Lsh (sedimen-
tation of open and compacted chromatin was confirmed
by gel electrophoresis (Figure 3(b))). Three Lsh peaks were
observed across the gradient (Figure 3(b): lanes 2–6; lanes
12–19; lanes 21–25) implying that Lsh exists in mouse cells in
both monomeric (top of gradient; open chromatin) and in
oligomeric nucleosomal fractions (middle (bulk chromatin)
and bottom of gradient (compact chromatin)).
Taking the Lsh-chromatin association and Lsh:Dnmt1
interaction data, we tested the hypothesis that Lsh recruits
Dnmt1 to chromatin by combining Lsh siRNA knockdown
withMNase dependent Dnmt1-chromatin release [40].Three
different siLsh duplexes were transfected into 293T cells
(Figure 3(c)) where siLsh#3 achieved highest knockdown of
endogenous Lsh levels. In non-siRNA treated cells, Dnmt1 is
released after MNase treatment; in contrast Dnmt1 is found
in the supernatant of non-MNase treated Lsh knockdown
p53−/− cells (Figure 3(d); compare untreated lanes of both top
panel western blots). Emerin was used as a control protein,
which is not chromatin bound under the conditions used.
Densitometry of the western blots was used to calculate
a Dnmt1-emerin ratio which illustrates the shift of Dnmt1
from “bound” (no siLsh) to enrichment in the “unbound”
(siLsh#3) fraction. These findings suggest the association of
Dnmt1 with chromatin can be Lsh dependent.
4. Conclusions
A series of investigations have implicated Lsh as a globalDNA
methylation accessory factor alongside other polypeptides
including Dnmt1, Dnmt3a, and Dnmt3b [27, 28]. This role
for Lsh was initiated by experiments in DDM1−/− plants
(DDM1 is the Arabidopsis Lsh orthologue) showing global
hypomethylation in these mutants at repeat sequences [24].
This hypothesis was supported when Lsh was knocked out in
mice (by two similar strategies) [30, 31] leading to postnatal
lethality with concomitant losses in DNA methylation in
repeat sequences and more recently at the HoxA gene cluster
[51]. This wholesale hypomethylator phenotype in mice was
explained byZhu and colleagueswith the finding that Lsh and
the de novo methyltransferases (Dnmt3a and Dnmt3b) can
interact and contribute to the silencing of an episomal trans-
gene independent of DNA replication [28]. We contribute to
the current view of Lsh function by reporting that (a) Lsh is
essential for frog and fish embryonic development; (b) Lsh
and Dnmt1 can associate in vivo and interact directly in vitro;
(c) Lsh recruitment to heterochromatin can be augmented
by HP1𝛼; (d) the association of Dnmt1 with chromatin is
mediated by Lsh.
Interestingly, the phenotype of frog and fishmorphants is
relatively late-onset (subsequent to themidblastula transition
(MBT) and in most cases after neurulation), which is in con-
trast to phenotypes associated with knockdown experiments
of other proteins linked toDNAmethylation such as xDnmt1,
xKaiso, and xMBD3 [33, 34, 52]. One possibility is that
abundant stores of maternal xLsh protein are not depleted by
xLMOuntil later developmental stage (i.e., neurula onwards).
An alternative is that Lsh is not essential in early Xenopus
embryonic genomic silencing. Moreover, we do not see any
changes in global DNAmethylation until long after the MBT
at the tailbud and tadpole stages. The phenotypic effect of
Lsh depletion in frogs and zebrafish is not associated with
loss of any particular germ layer or organ, which dovetails
with the range of phenotypes observed in DDM1−/− and
antisense MET1 plants [53, 54]. Similar to what we have
established for frogs and fish, in relation to the mouse Lsh
phenotype, early development is relatively normal afterwhich
mice die either perinatally [30] or a few weeks after birth [31].
These studies report that although embryonic development
is overall normal, knockout embryos fail after birth due to
a range of defects including renal dysfunction, respiratory
problems (lung defects), growth retardation, and an aging
phenotype.
In terms of DNA methylation in frog embryo mor-
phants, we observed losses at the high-copy interspersed
repeat sequence xSatI. We previously demonstrated that this
repeat is heavily methylated in all developmental stages
but that this CpG methylation is lost in severely xDnmt1-
depleted genomic DNA [42]. The kinetics and extent of
xSatI hypomethylation between Lsh and Dnmt1 morphants
are different, with partial losses of methylation observed
in Lsh tadpole morphants (compared to complete loss at
MBT for in Dnmt1 antisense RNA injected mutants). It
is possible that Lsh is not involved in maintaining DNA
methylation at this repeat in early development but has a
more prominent role at late stages. Dnmt1 is highly abundant
in early Xenopus development and may be sufficient to
mediate early repression [34], but as development proceeds
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Figure 3: Lsh is associated with chromatin and is required for Dnmt1-chromatin association. (a) MNase treatment of 293T nuclei indicates
that endogenous Lsh andDnmt1 are chromatin bound (see untreated lanes). (b) Endogenous Lsh is associatedwith soluble chromatin. Sucrose
gradient sedimentation was used to fractionate 3T3 soluble chromatin and both protein and genomic DNA were isolated from each fraction.
Fractionation of chromatin was validated by DNA gel electrophoresis of all gradient fractions. Western blotting of fractions shows that mLsh
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its levels are titrated out after multiple cell divisions perhaps
permitting Lsh to have a more prominent role in specifying
repression at discrete loci.
Here we show a novel direct in vivo interaction between
Lsh and Dnmt1. Existing data has implied that Lsh interacts
predominantly with the de novo methyltransferases Dnmt3a
andDnmt3b inMEFs, while this interaction occurs bymeans
of HDAC1 andHDAC2 in transformed cancer cells (HCT116)
[27]. Similar to work from Yan et al. [29], we propose that
Lsh and Dnmt1 colocalisation in somatic cells is a rare event
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(<15%). Although this interaction is rare, it is likely to be
physiologically relevant as our in vitro experiments show
a direct interaction between Lsh and Dnmt1 biochemically
under physiological salt (∼150mM) conditions and the more
stringent conditions (400mM) employed previously by [27],
implying that the interaction is robust even in the presence
of ethidium bromide (an inhibitor of DNA:protein interac-
tions). Furthermore, we are able to show immunoprecipita-
tion between Lsh andDnmt1 in SW620 colorectal cancer cells
indicating the proteins are partners in vivo.This demonstrates
for the first time that while Lsh and Dnmt1 can associate,
the in vivo protein association may be transient and or cell-
cycle regulated. It is a possibility that Lsh cooperates with
de novo methylation activities in early embryonic cells [28,
55] and that the Lsh and Dnmt1 association is crucial for
differentiated and fate-determined soma [27]. Furthermore,
Xenopus Dnmt3 may not be a de novomethylation candidate
partner for Lsh as sequence database searches revealed only
one Dnmt3 orthologue in the Xenopus tropicalis genome that
is most similar to murine Dmnt3a2, a truncated form of
Dnmt3a lacking the N-terminal 219 amino acids involved in
the repression of euchromatic loci [56].The same homologue
is the only Dnmt3-like protein present in the Xenopus laevis
EST database. Expression analysis of the Xenopus laevis
transcript indicates that it is only present in later stages
of development (Supplementary S8), which argues against
Xenopus Lsh and Dnmt3a2 having a role in maintaining
global DNA methylation during early embryogenesis.
Nuclear protein localization studies give useful indica-
tions of protein function. This is further assisted by the
clear staining of blocks of silent pericentric heterochromatin
by DAPI (4󸀠,6-diamidino-2-phenylindole) in murine cells
which is composed of tandem repeats of satellite sequences.
Involvement of Lsh in heterochromatin structure has been
reported in mouse Lsh−/− cells which accumulate the acti-
vating H3K4me2 mark and by its localisation to DAPI bright
spots. In unsynchronised somatic cells (MEFs/3T3/N2a) we
rarely (<15%) observe Lsh that is coincident with pericentric
heterochromatic foci. Replication of the mammalian genome
is organised into early, mid, and late replicating loci with
regions containing high gene density early, interspersed
repeats later, and condensed heterochromatin at the latest
stages of S-phase. Diffuse Lsh staining in >85% of cells may
be indicative of localisation at euchromatic gene regions and
interspersed repeat sequences. We propose a model where
Lsh can cooperate with Dnmt1 at condensed pericentric
heterochromatin during late S-phase but these protein part-
ners may also have a role in repressing gene expression
(i.e., Hox genes, [51]) and nonheterochromatic interspersed
repeat elements and this is facilitated by HP1𝛼 (see model in
Figure 4).
Evidence for a model where Lsh can recruit Dnmt1 to
chromatin is strengthened by ourMNase release assays which
have also been used to demonstrate the association between
MeCP2 and chromatin [40]. We show that both Dnmt1 and
Lsh are tightly coupled to chromatin in human 293T cells.
Using an siRNA strategy to deplete endogenous Lsh we show
that the Dnmt1-chromatin association requires normal levels
of Lsh. These data are consistent with the idea that Lsh can
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Figure 4: Model for Lsh and Dnmt1 cooperation in silencing.
(a) Model for Lsh:Dnmt1 mediated repression. In wild type cells,
the H3K9trime mark acts as a ligand in HP1𝛼 recruitment to
silent regions of the genome. Taking together our data and that of
others, both Dnmt1 and Lsh can be associated with HP1𝛼 (perhaps
requiring HDACs 1 and 2) thereby allowing the parallel docking
of DNA methyltransferase and chromatin remodelling activities
to silent loci. (b) In Lsh depleted cells (and knockout plants and
animals), targeting of Dnmt1 is diminished leading to reduced DNA
methylation maintenance and partial genomic hypomethylation.
The accumulation of the activating H3K4me2 mark in Lsh−/− cells
may be a downstream effect of DNA hypomethylation.
recruit and modify local nucleosome positioning or act as
a cofactor for Dnmt1 binding to chromatin, which would
explain the hypomethylation phenotype in Lsh mutants.
Interestingly, van Heeringen and colleagues [57] have shown
that specific nonmethylated Xenopus tropicalis sequences are
genetically instructive for H3K27me3 deposition, a finding
which supports the opposing paradigm that heterochromatin
is epigenetically regulated through recruitment of Dnmt1 to
these repetitive genomic regions. Moreover, the action of
HDACs may be critical for this process as Lsh-mediated
repression of a reporter is alleviated in part by treatment
with TSA (data not shown) and the observation that Dnmt1
and Lsh may signal through HDACs [27] (see model in
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Figure 4). To definitively test these possibilities, sequential
ChIP-Seq with antisera against Lsh and Dnmt1 (and Lsh and
Dnmt3a/3b)will reveal the genetic targets of these complexes.
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